✦ LIBER ✦

Low-grade gliomas in older patients : Long-term follow-up from Mayo Clinic

✍ Scribed by David A. Schomas; Nadia N. Laack; Paul D. Brown

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 177 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24444

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term follow-up of patients with a p

Long-term follow-up of patients with a painless inguinal hernia from a randomized clinical trial

✍ L. Chung; J. Norrie; P. J. O'Dwyer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

Ewing's sarcoma: Long-term follow-up in

Ewing's sarcoma: Long-term follow-up in 49 patients treated from 1967 to 1989

✍ Hedy Mameghan; Richard J. Fisher; Darcy O'Gorman-Hughes; Edward H. Bates; Ronald 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 842 KB

Clinical and long-term follow-up study i

Clinical and long-term follow-up study in patients with spontaneous subarachnoid haemorrhage of unknown aetiology

✍ S. Kawamura; N. Yasui 📂 Article 📅 1990 🏛 Springer Vienna 🌐 English ⚖ 653 KB

123I-IBZM binding compared with long-ter

123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism

✍ Dr. Johannes Schwarz; Klaus Tatsch; Thomas Gasser; Guy Arnold; Oliver Pogarell; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB

We performed a prospective clinical follow up (mean follow up, 36 months; range, 24-56 months) of 65 patients with de novo parkinsonism in whom imaging of dopamine D2 receptors was performed before the initiation of dopaminomimetic therapy by means of 123I-iodobenzamide-single-photon-emission comput

The value of long-term follow-up of mand

The value of long-term follow-up of mandibular advancement surgery in patients with a low to normal mandibular plane angle

✍ J. P. B. Bouwman; D. B. Tuinzing; P. J. Kostense; R. A. van Teeseling; H. Mokhta 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 496 KB

The cyclophosphamide, vincristine, predn

The cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin, and procarbazine (COPBLAM-I) regimen for intermediate-grade non-Hodgkin's lymphoma. Long term follow-up in 51 patients

✍ Ofer Shpilberg; Jacob Shif; Angela Chetrit; Bracha Ramot; Isaac Ben-Bassat 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 2 views

Background. Cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin, and procarbazine (COP-BLAM-I) is a second generation combination chemotherapy for intermediate-grade non-Hodgkin's lymphoma (NHL). Since the first report by Laurence et al. in 1982, only a few series were reported on the